Meridia risks warrant restrictions or withdrawal: FDA panel | theheart.org theHeart.org: Lipid and Metabolic news related to heart conditions.
Links shared publicly online about this topic.
- 871total visits
Meridia risks warrant restrictions or withdrawal: FDA panel | theheart.org theHeart.org: Lipid and Metabolic news related to heart conditions.
Studies and Clinical trials on Metabolic and Lipid issues affecting the heart. Articles by heartwire staff and renowned cardiologists. Partnership with Baylor.
View full resource at theheart.org
Tags: Heart, Metabolic, Clinical Trial, FDA, Cardiologist, Cardiology, News
Most Recently Shared on September 15, 2010 at 9:06 pm By:
FDA advisors say sibutramine's CV risks warrant harsher restrictions or withdrawal: Six members of the FDA panel v... http://bit.ly/alR58l
Advertisement
